Palovarotene
Orphan DrugFDA Approved
Contents
Description
Palovarotene is a retinoic acid receptor gamma (RARγ) selective agonist used to treat fibrodysplasia ossificans progressiva (FOP). It works by reducing new heterotopic ossification (HO) volume in patients with FOP.
Indications & Therapeutic Use
Fibrodysplasia Ossificans Progressiva
Linked Diseases:
Global Availability (1 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — |
Buy / Source Palovarotene — GNH India
10 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Palovarotene products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Palovarotene
| Generic Name | Palovarotene |
| Brands | 1 brand available |
| Active Ingredient | Palovarotene |
| Drug Class | Fibrodysplasia Ossificans Progressiva |
| Manufacturer | Ipsen |
| Dosage Forms | Capsule |
| Medical Code | M04AA05 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT03997618 |
| Countries | 1 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations2 Validated Nodes